Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Featured News
May 16, 2016
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community